Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment
JP Leider, PhD comments on privilege and fairness regarding access to the increasingly in-demand treatment.
JP Leider, PhD comments on privilege and fairness regarding access to the increasingly in-demand treatment.
